A BILL 
To amend the Controlled Substances Act to require the At-
torney General to make procurement quotas for opioid 
analgesics publicly available, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Opioid Quota Open-
4
ness, Transparency, and Awareness Act of 2019’’ or the 
5
‘‘Opioid QuOTA Act’’. 
6
05:26 May 14, 2019
\\ALPHA3\E\BILLS\H2582.IH
H2582
2 
•HR 2582 IH
SEC. 2. PUBLIC REPORTING OF PROCUREMENT QUOTAS 
1
FOR OPIOID ANALGESICS. 
2
(a) IN GENERAL.—Section 306 of the Controlled 
3
Substances Act (21 U.S.C. 826) is amended by adding at 
4
the end the following: 
5
‘‘(j)(1) In this subsection, the term ‘opioid procure-
6
ment quota’ means a quota established by the Attorney 
7
General for the quantity of opioid analgesics that a reg-
8
istered manufacturer may procure for purposes of manu-
9
facturing dosage forms or other substances. 
10
‘‘(2) The Attorney General shall make publicly avail-
11
able, including through the Web site of the Drug Enforce-
12
ment Administration— 
13
‘‘(A) the quantity of the opioid procurement 
14
quota for each registered manufacturer for each 
15
year; 
16
‘‘(B) the quantity of opioid analgesics procured 
17
by each registered manufacturer for each year; and 
18
‘‘(C) except as provided under paragraph (3)— 
19
‘‘(i) a copy of the form or other applica-
20
tion, including any attachments or exhibits, 
21
submitted by each registered manufacturer re-
22
questing an opioid procurement quota; and 
23
‘‘(ii) a copy of each year-end or annual re-
24
port relating to the procurement or use of 
25
opioid analgesics submitted to the Attorney 
26
05:26 May 14, 2019
\\ALPHA3\E\BILLS\H2582.IH
H2582
3 
•HR 2582 IH
General by a registered manufacturer to whom 
1
the Attorney General has issued an opioid pro-
2
curement quota. 
3
‘‘(3) Upon a request by a registered manufacturer as-
4
serting that a document or information described in clause 
5
(i) or (ii) of paragraph (2)(C) is exempt from disclosure 
6
under section 552(b)(4) of title 5, United States Code, and 
7
to the extent that the Attorney General determines that 
8
the document or information is exempt from disclosure 
9
under such section 552(b)(4), the document or informa-
10
tion may be excluded from public disclosure under para-
11
graph (2).’’. 
12
(b) GAO REPORT.—The Comptroller General of the 
13
United States shall submit to Congress a report that, for 
14
the 1-year period beginning on the date of enactment of 
15
this Act— 
16
(1) details— 
17
(A) the number of instances in which a 
18
registered manufacturer made a request de-
19
scribed in section 306(j)(3) of the Controlled 
20
Substances Act, as added by subsection (a), 
21
with respect to a document or information; and 
22
(B) the number of instances in which the 
23
Attorney General determined such a document 
24
or information was exempt from disclosure 
25
05:26 May 14, 2019
\\ALPHA3\E\BILLS\H2582.IH
H2582
4 
•HR 2582 IH
under section 552(b)(4) of title 5, United 
1
States Code; and 
2
(2) evaluates the extent of the independent 
3
evaluation conducted by the Attorney General of re-
4
quests described in section 306(j)(3) of the Con-
5
trolled Substances Act. 
6
Æ 
05:26 May 14, 2019
\\ALPHA3\E\BILLS\H2582.IH
H2582
